2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Saturday, June 2, 2018

5:30pm-7:30pm: Do Protocol Biopsies in the Highly Sensitized Improve Renal Allograft Survival? A Single Center Evaluation of 2 Year Graft Function

S. Kuppachi, R. Kalil, M. Fraer, M. Sanders, M. Swee, Z. Stewart, C. Thomas.

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?

M. Morton,¹ K. Daga,² P. Klapper,² M. Picton,¹ P. Vallely.²

Poster Session A: Kidney Transplant Goes Viral • Hall 4EF

5:30pm-7:30pm: Does Biliary Duct Reconstruction Technique Impact Liver Transplantation Outcomes?

R. Shahbazov,¹ M. Kessel,² K. Knapp,² F. Azari,² S. Tsutsui,³ A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹

Poster Session A: Liver Retransplantation and Other Complications • Hall 4EF

5:30pm-7:30pm: Donor TM6SF2 rs58542926 Genotype is a Risk Factor for Liver Graft Steatosis

I. Mikova,¹ M. Neroldova,² J. Hubacek,² D. Dlouha,² L. Kolesar,³ M. Jirsa,² E. Honsova,⁴ E. Sticova,⁴ V. Lanska,⁵ J. Spicak,¹ P. Trunecka.¹

Poster Session A: Liver Retransplantation and Other Complications • Hall 4EF

5:30pm-7:30pm: Donor and Procedural Variability in DCD Liver Transplant: Is It Time to Come to a Consensus?

L. Ruffolo, M. Balceniuk, R. Hernandez Alejandro.

Poster Session A: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Hall 4EF

5:30pm-7:30pm: Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation

O. van Leeuwen,¹ M. van Reeven,² M. Fujiyoshi,¹ V. de Meijer,¹ R. de Kleine,¹ M. de Boer,¹ J. de Jonge,² J. Ijzermans,² W. Polak,² R. Porte.¹

Poster Session A: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Hall 4EF

5:30pm-7:30pm: Donor T Cells Undermine the Graft-Protective Effect of DST Plus Anti-CD154

M. Iglesias, M. Chicco, W. Lee, G. Brandacher, G. Raimondi.

Poster Session A: Tolerance / Immune Deviation • Hall 4EF

5:30pm-7:30pm: Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes for Identifying Kidney Transplant Rejection

M. Weir,¹ D. Hiller,² J. Yee,² A. Matas.³

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: Double Deficiency of Gelatinase-A and Gelatinase-B Does Not Protect against Hepatic Ischemia Reperfusion Injury

S. Duarte, P. Matian, S. Ma, R. Busuttil, A. Coito.

Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement • Hall 4EF

5:30pm-7:30pm: DSA-Level Liver Availability and Liver Utilization

S. Zhou, M. Bowring, A. Massie, S. Gentry, D. Segev.

Poster Session A: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Hall 4EF